3 ms·
The point about regulatory capture is secondary to the increase in cost. But there are patients going from high cost to low cost countries (linked below). There
by smokeyj 9y ago
The point about regulatory capture is secondary to the increase in cost. But there are patients going from high cost to low cost countries (linked below). There's also "big pharma" that is using IP regulations to limit what choices consumers have. I realize IP is another can of worms but it's still an example of regulation that is having the exact opposite of the desired outcome.
I would totally be for "sane" regulation, where autonomous driving components can be inexpensively tested and certified. I fear the more likely outcome will involve keeping costs prohibitively high. Considering how many people die on the road each year it would make sense for the state to sponsor a non-proprietary solution. Off the top of your head, in terms of the number of lives that can be saved per dollar - can you think of a better investment?
My feelings about autonomous cars is largely influenced by how terrible humans are at driving. At this point I'd rather trust a decent self-driving car than the average human.
*https://www.npr.org/templates/story/story.php?storyId=16294182 https://www.npr.org/templates/story/story.php?storyId=162941...